Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Thera IX > 09 Chemotherapy Induced Anemia (CIA) Pak > Flashcards

09 Chemotherapy Induced Anemia (CIA) Pak Flashcards

1
Q

What is Grade 0 in the Anemia Grading Scale?

A

Males Hgb: 14-18, Females: 12-16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Grade 1 in the Anemia Grading Scale?

A

Mild. Hgb: 10-normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Grade 2 in the Anemia Grading Scale?

A

Moderate. Hgb: 8-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Grade 3 in the Anemia Grading Scale?

A

Severe. Hgb: 6.5-7.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Grade 4 in the Anemia Grading Scale?

A

Life-Threatening. Hgb: < 6.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What what Anemia Grade do symptoms usually start?

A

Grade 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the symptoms associated with Grade 2 (moderate) anemia?

A

Fatigue. Dyspnea. HA. Palpitations. Chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the result of chronic anemia?

A

Can result in severe organ damage affecting the kidneys, CNS, CVS, lungs, immune system, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a low baseline hemoglobin level?

A

Males < 13.5, Females < 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the general steps in the management of CIA?

A

1) Treat underlying deficiencies (iron, folic acid, vitamin B12). 2) Packed red blood cells (PRBC) transfusion. 3) Erythropoietin-stimulating agents (ESA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When is transfusion indicted?

A

ASYMPTOMATIC Grade 3 with comorbidities (CHF; CHD; CVD; chronic pulmonary disease, high risk: progressive decline in Hgb w/ recent chemo or radiation). SYMPTOMATIC Grade 2 (sustained tachycardia, tachypnea, chest pain, dyspnea on exertion, lightheadedness, syncope, severe fatigue preventing work and usual activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Hgb goal in Asymptomatic Grade 3 anemia w/ comorbidities?

A

7-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the Hgb goal in Symptomatic Grade 2 anemia?

A

8-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How much will 1 unit PRBC raise Hgb?

A

By 1g/dL and Hct by 3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the benefits of RBC Transfusion?

A

Rapid increase in Hgb and Hct. Rapid improvement in fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the risks with RBC Transfusion?

A

Transfusion reactions (hemolytic, febrile, non-hemolytic, lung injury, chest pain, uticaria, etc.). Congestive heart failure. Virus transmission. Bacterial contamination. Increased thrombotic events. IRON OVERLOAD (at risk ~100mL/kg PRBC in lifetime and serum ferritin > 1000 mcg/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the normal iron levels?

A

50-150mcg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the normal ferritin levels?

A

12-300mcg/L in males. 12-150mcg/L in females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the symptoms of Iron Overload?

A

Non-specific: Lethargy, weight loss, abdominal pain, joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the indication for Deferoxamine (Desferal)?

A

Acute iron intoxication. Chronic iron overload secondary to multiple transfusions

21
Q

What is the MOA of Deferoxamine?

A

Complexes with trivalent ions (non-specific) that are removed by the kidneys

22
Q

How is Deferoxamine (Desferal) administered?

A

Rate of IV infusion NTE 15mg/kg/hr (to prevent flushing, uticaria, hypotension, and shock)

23
Q

When is Deferoxamine (Desferal) contraindicated?

A

Severe renal disease or anuria (renally eliminated)

24
Q

What are some DDIs with Deferoxamine?

A

Vitamin C > 200mg/day –> risk of cardiac impairment (rare). Prochlorperazine –> may lead to temporary impairment of consciousness

25
Q

When is Deferasirox (Exjade) indicated?

A

Chronic iron overload d/t blood transfusion. PO ONLY

26
Q

What is the MOA of Deferasirox (Exjade)?

A

Selectively binds iron which is excreted primarily through the feces

27
Q

What is the administration of Deferasirox (Exjade) like?

A

DO NOT chew or swallow whole tablets. Disperse tablet in water, orange juice, or apple juice into a suspension. Take on empty stomach ~30 mins AC

28
Q

How is Deferasirox (Exjade) supplied?

A

125mg, 250mg, and 500mg tablets for suspension

29
Q

What are some DDIs with Deferasirox (Exjade)?

A

Aluminum-containing antacid can decrease absorption (separate 1hr before 2hr after meals)

30
Q

What is a BBW for Deferasirox (Exjade)?

A

May cause renal impairment/failure, hepatic impairment failure, and gastrointestinal hemorrhage

31
Q

When is Deferiprone (Ferriprox) indicated?

A

Transfusional iron overload d/t THALASSEMIA syndromes with inadequate response to other chelation therapy. PO only

32
Q

What is the MOA of Deferiprone (Ferriprox)?

A

Selectively binds iron that are removed by the kidneys

33
Q

How is Deferiprone (Ferriprox) dosed?

A

25mg/kg PO TID, max 33mg/kg TID. Take with food

34
Q

What are some DDIs with Deferiprone (Ferriprox)?

A

Antacids can decrease absorption (separate by 4 hours)

35
Q

What is a BBW for Deferiprone (Ferriprox)?

A

May cause agranulocytosis

36
Q

What is the MOA of Erythropoiesis?

A

Kidney senses hypoxia (anemia) and increases endogenous erythropoietin production. Erythropoietin acts on the E-progenitor cells in the bone marrow to produce new red blood cells. Kidney senses increased tissue oxygenation. Kidney decreases erythropoietin production

37
Q

How is Epoetin alfa (Epogen, Procrit) dosed?

A

40,000 units subQ weekly

38
Q

How is Darbepoetin alfa (Aranesp) dosed?

A

500mcg SubQ every three weeks

39
Q

What is alternative dosing for Darbepoetin alfa (Aranesp)?

A

100mcg SubQ weekly. 200mcg SubQ every two weeks

40
Q

What are contraindications to ESA?

A

Uncontrolled HTN. Hypersensitivity to human albumin

41
Q

What are the boxed warnings for ESAs?

A

Cancer Patients (decrease OS and/or increase tumor progression or recurrence in clinical studies with breast, non-small cell lung, head and neck, lymphoid and cervical CA patients (studies targeted Hgb > 12g/dL)). Chronic Renal Failure patients (Increased risk of death, serious cardiovascular events, and stroke (studies targeted Hgb > 13), dosing should be individualized to achieve and maintain Hgb at 10-12 g/dL)

42
Q

What can be done to decrease the boxed warnings of ESAs?

A

Use lowest dose needed to void RBC transfusion, do not initiate if Hgb > 10. Use only for treatment of myelosuppressive therapy-related anemia. Do not use if anticipated outcome for therapy is CURE. Discontinue following the completion of chemotherapy course (within 6 weeks)

43
Q

What are the more common ADRs associated with ESA?

A

HTN/Hypotension

44
Q

What is the iron monitoring and supplementation like before starting ESA?

A

Assess iron studies (serum, total iron binding capacity (TIBC), and serum ferritin). Periodic monitoring of iron studies may be necessary every 3 months if ESA therapy is to continue

45
Q

What are the common ADRs associated with IV Iron Supplements?

A

Hypotension, N/V/D, pain, HTN, dyspnea, pruritus, HA, and dizziness

46
Q

Which IV Iron Supplements have the most ADRs?

A

Iron Dextran > Ferric Gluconate > Iron Sucrose

47
Q

What is the max dose of IV Iron Supplements like?

A

1,000mg max, except Iron Dextran (can be higher)

48
Q

Which cancer patients is ESA therapy NOT indicated?

A

Patients NOT receiving concomitant myelosuppressive chemotherapy. Patients with myeloid malignancies. Patients with Hgb level of 10 or greater at time of ESA initiation. Patients receiving myelosuppressive therapy when the anticipated outcome is CURE. Patients whose anemia is due to other treatable causes. Patients receiving radiotherapy alone. Patients with uncontrolled HTN

Thera IX (29 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions